Cargando…
Drug Repositioning for Refractory Benign Tumors of the Central Nervous System
Drug repositioning (DR) is the process of identifying novel therapeutic potentials for already-approved drugs and discovering new therapies for untreated diseases. DR can play an important role in optimizing the pre-clinical process of developing novel drugs by saving time and cost compared with the...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455557/ https://www.ncbi.nlm.nih.gov/pubmed/37629179 http://dx.doi.org/10.3390/ijms241612997 |